DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 075631
NDA 075631 describes KETOROLAC TROMETHAMINE, which is a drug marketed by Amphastar Pharm, Apotex Inc, Apothecon, Baxter Hlthcare Corp, Bedford, Cycle Pharms Ltd, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Luitpold, Mylan Labs Ltd, Sagent Pharms, Sandoz Inc, Sun Pharma Global, West-ward Pharms Int, Wockhardt, Akorn, Mylan, Pliva, Teva, and Watson Labs, and is included in thirty-nine NDAs. It is available from fifty-one suppliers. Additional details are available on the KETOROLAC TROMETHAMINE profile page.
The generic ingredient in KETOROLAC TROMETHAMINE is ketorolac tromethamine. There are eighteen drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the ketorolac tromethamine profile page.
The generic ingredient in KETOROLAC TROMETHAMINE is ketorolac tromethamine. There are eighteen drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the ketorolac tromethamine profile page.
Summary for 075631
| Tradename: | KETOROLAC TROMETHAMINE |
| Applicant: | Baxter Hlthcare Corp |
| Ingredient: | ketorolac tromethamine |
| Patents: | 0 |
| Therapeutic Class: | Analgesics Anti-inflammatory Agents Ophthalmic Agents |
| Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 075631
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 30MG/ML | ||||
| Approval Date: | Jun 29, 2001 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 15MG/ML | ||||
| Approval Date: | Jun 29, 2001 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
